Skip to main content
Signal8

Paul Andrea

SEC insider (Form 3/4/5 filer). CIK 0001863130. Chief Legal Officer at Zentalis Pharmaceuticals, Inc. (ZNTL). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 3, 2025. Located in SAN DIEGO, CA.

Companies Paul Andrea has filed insider reports for

  • Zentalis Pharmaceuticals, Inc. (ZNTL): Officer, Chief Legal Officer
Paul Andrea profile photo

Paul Andrea

CIK: 0001863130

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Zentalis Pharmaceuticals, Inc. logo
ZNTL

Zentalis Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Zentalis Pharmaceuticals, Inc. logo
    ZNTL

    Zentalis Pharmaceuticals, Inc.

    Feb 3, 2025
    Award
    Direct
    934K shares-
  • Zentalis Pharmaceuticals, Inc. logo
    ZNTL

    Zentalis Pharmaceuticals, Inc.

    Feb 3, 2025
    Sale
    Direct
    13.2K shares at avg. $1.71$23K

1-2 of 2